BioMS jumps after Eli Lilly deal

BioMS (TSX:MS) gained C$1.02 (38%) to C$3.72 on Tuesday after reporting late Monday that it granted LLY an exclusive, worldwide license to MBP8298. The synthetic myelin basic protein (MBP) peptide is ...